Literature DB >> 20445567

Both copy number and sequence variations affect expression of human DEFB4.

M Groth1, C Wiegand, K Szafranski, K Huse, M Kramer, P Rosenstiel, S Schreiber, J Norgauer, M Platzer.   

Abstract

Copy number variations (CNVs) were found to contribute massively to the variability of genomes. One of the best studied CNV region is the beta-defensin cluster (DEFB) on 8p23.1. Individual DEFFB copy numbers (CNs) between 2 and 12 were found, whereas low CNs predispose for Crohn's disease. A further level of complexity is represented by sequence variations between copies (multisite variations, MSVs). To address the relation of DEFB CN and MSV to the expression of beta-defensin genes, we analyzed DEFB4 expression in B-lymphoblastoid cell lines (LCLs) and primary keratinocytes (normal human epidermal keratinocyte, NHEK) before and after stimulation with lipopolysaccharide, tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma). Moreover, we quantified one DEFB4 MSV in DNA and mRNA as a marker for variant-specific expression (VSE) and resequenced a region of approximately 2 kb upstream of DEFB4 in LCLs. We found a strong correlation of DEFB CN and DEFB4 expression in 16 LCLs, although several LCLs with very different CNs exhibit similar expression levels. Quantification of the MSV revealed VSE with consistently lower expression of one variant. Costimulation of NHEKs with TNF-alpha/IFN-gamma leads to a synergistic increase in total DEFB4 expression and suppresses VSE. Analysis of the DEFB4 promoter region showed remarkably high density of sequence variabilities (approximately 1 MSV/41 bp).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20445567     DOI: 10.1038/gene.2010.19

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  24 in total

1.  Gene inactivation and its implications for annotation in the era of personal genomics.

Authors:  Suganthi Balasubramanian; Lukas Habegger; Adam Frankish; Daniel G MacArthur; Rachel Harte; Chris Tyler-Smith; Jennifer Harrow; Mark Gerstein
Journal:  Genes Dev       Date:  2011-01-01       Impact factor: 11.361

Review 2.  Human Genetic Variation and HIV/AIDS in Papua New Guinea: Time to Connect the Dots.

Authors:  Rajeev K Mehlotra
Journal:  Curr HIV/AIDS Rep       Date:  2018-12       Impact factor: 5.071

3.  Activity, expression and genetic variation of canine β-defensin 103: a multifunctional antimicrobial peptide in the skin of domestic dogs.

Authors:  Brian C Leonard; Stanley L Marks; Catherine A Outerbridge; Verena K Affolter; Anchasa Kananurak; Amy Young; Peter F Moore; Danika L Bannasch; Charles L Bevins
Journal:  J Innate Immun       Date:  2012-01-19       Impact factor: 7.349

Review 4.  Genetics of ANCA-associated Vasculitides.

Authors:  Manuel F Ugarte-Gil; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2014-07       Impact factor: 4.592

5.  Persistent nasal carriage of Staphylococcus aureus is associated with deficient induction of human beta-defensin 3 after sterile wounding of healthy skin in vivo.

Authors:  Philipp Zanger; Dennis Nurjadi; Bernadette Vath; Peter G Kremsner
Journal:  Infect Immun       Date:  2011-04-04       Impact factor: 3.441

6.  A preliminary assessment of Toll-like receptor and β-defensin gene polymorphisms in Papua New Guinea - what does it mean for HIV/AIDS?

Authors:  Barne Willie; Janet Gare; Christopher L King; Peter A Zimmerman; Rajeev K Mehlotra
Journal:  P N G Med J       Date:  2017 Mar-Jun

7.  Low DEFB4 copy number and high systemic hBD-2 and IL-22 levels are associated with dermatophytosis.

Authors:  Sameh W Jaradat; Susana Cubillos; Nadine Krieg; Katja Lehmann; Bassam Issa; Susann Piehler; Sylvi Wehner-Diab; Uta-Christina Hipler; Johannes Norgauer
Journal:  J Invest Dermatol       Date:  2014-09-01       Impact factor: 8.551

8.  Associations between vaginal bacteria and levels of vaginal defensins in pregnant women.

Authors:  Caroline Mitchell; Michelle L Gottsch; Congzhou Liu; David N Fredricks; Deborah B Nelson
Journal:  Am J Obstet Gynecol       Date:  2012-11-19       Impact factor: 8.661

9.  Variation in human β-defensin genes: new insights from a multi-population study.

Authors:  R K Mehlotra; P A Zimmerman; A Weinberg; R J Jurevic
Journal:  Int J Immunogenet       Date:  2012-11-29       Impact factor: 1.466

10.  β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease.

Authors:  Angelica Vittori; Michael Orth; Raymund A C Roos; Tiago F Outeiro; Flaviano Giorgini; Edward J Hollox
Journal:  J Huntingtons Dis       Date:  2013-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.